RISS 학술연구정보서비스

검색

인기 검색어

    다국어 입력

    http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

    변환된 중국어를 복사하여 사용하시면 됩니다.

    예시)
    • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
    • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
    닫기
    KCI등재 SCOPUS

    Three-Phase CT Findings of Combined Hepatocellular and Cholangiocarcinomas

    한글로보기

    https://www.riss.kr/link?id=A104533723

    • 0

      상세조회
    • 0

      다운로드
    서지정보 열기
    • 내보내기
    • 내책장담기
    • 공유하기
    • 오류접수

    부가정보

    다국어 초록 (Multilingual Abstract) kakao i 다국어 번역

    Purpose: To evaluate three-phase CT findings of combined hepatocellular and cholangiocarcinomas (cHCC-CCs), with an emphasis on the enhancement pattern.
    Materials and Methods: We retrospectively analyzed CT findings in 11 patients with histopathologically proven 11 cHCC-CCs. Three-phase CT findings of cHCC-CCs during the arterial phase (AP), portal venous phase (PVP), and equilibrium phase (EP) were evaluated, based on the morphologic and enhancement pattern.
    Results: Two (18%) of all the tumors showed arterial enhancement during the AP and delayed washout during the PVP and EP. Three tumors (27%) showed no arterial enhancement and delayed washout or delayed enhancement during the same phases. The remaining six tumors (55%) showed both arterial enhancement and delayed enhancement during the same phases.
    Conclusion: Three-phase CT findings of cHCC-CCs were found to be variable, according to the histologic proportion of HCC or CC components. However, cHCC-CC could be considered when a tumor shows both arterial enhancement and delayed enhancement at three-phase CT.
    번역하기

    Purpose: To evaluate three-phase CT findings of combined hepatocellular and cholangiocarcinomas (cHCC-CCs), with an emphasis on the enhancement pattern. Materials and Methods: We retrospectively analyzed CT findings in 11 patients with histopathologic...

    Purpose: To evaluate three-phase CT findings of combined hepatocellular and cholangiocarcinomas (cHCC-CCs), with an emphasis on the enhancement pattern.
    Materials and Methods: We retrospectively analyzed CT findings in 11 patients with histopathologically proven 11 cHCC-CCs. Three-phase CT findings of cHCC-CCs during the arterial phase (AP), portal venous phase (PVP), and equilibrium phase (EP) were evaluated, based on the morphologic and enhancement pattern.
    Results: Two (18%) of all the tumors showed arterial enhancement during the AP and delayed washout during the PVP and EP. Three tumors (27%) showed no arterial enhancement and delayed washout or delayed enhancement during the same phases. The remaining six tumors (55%) showed both arterial enhancement and delayed enhancement during the same phases.
    Conclusion: Three-phase CT findings of cHCC-CCs were found to be variable, according to the histologic proportion of HCC or CC components. However, cHCC-CC could be considered when a tumor shows both arterial enhancement and delayed enhancement at three-phase CT.

    더보기

    참고문헌 (Reference)

    1 Ozyilkan E, "virus antibody in patients with primary liver cancer (hepatocellular carcinoma, cholangiocarcinoma, and combined hepatocellular-cholangiocarcinoma) in Japan" 73 : 2002-2003, 1994

    2 Liver Cancer Study Group of Japan, "Survey and follow-up study of primary liver cancer in Japan. Report 13" 40 : 288-300, 1999

    3 "Surgical Treatments and Prognoses of Patients with Combined Hepatocellular Carcinoma and Cholangiocarcinoma" Springer, NY, USA 16 (16): 623-629, 2009

    4 Yamashita Y, "Sclerosing hepatocellular carcinoma: radiologic finding" 18 : 347-351, 1993

    5 Yeh MM, "Pathology of combined hepatocellular-cholangiocarcinoma" 25 : 1485-1492, 2010

    6 Kassahun WT, "Management of combined hepatocellular and cholangiocarcinoma" 62 : 1271-1278, 2008

    7 이정훈, "Long-term Prognosis of Combined Hepatocellular and Cholangiocarcinoma After Curative Resection Comparison With Hepatocellular Carcinoma and Cholangiocarcinoma" LIPPINCOTT WILLIAMS & WILKINS 45 : 69-75, 201101

    8 윤순호, "Intrahepatic Mass-forming Cholangiocarcinomas: Enhancement Patterns at Multiphasic CT, with Special Emphasis on Arterial Enhancement Pattern-Correlation with Clinicopathologic Findings" RADIOLOGICAL SOC NORTH AMERICA 260 (260): 148-157, 201107

    9 Ebied O, "Hepatocellular-cholangiocarcinoma: helical computed tomography findings in 30 patients" 27 : 117-124, 2003

    10 "Hepatocellular carcinoma variants: Radiologic-pathologic correlation" American Roentgen Ray Society 193 (193): W7-W13, 2009

    1 Ozyilkan E, "virus antibody in patients with primary liver cancer (hepatocellular carcinoma, cholangiocarcinoma, and combined hepatocellular-cholangiocarcinoma) in Japan" 73 : 2002-2003, 1994

    2 Liver Cancer Study Group of Japan, "Survey and follow-up study of primary liver cancer in Japan. Report 13" 40 : 288-300, 1999

    3 "Surgical Treatments and Prognoses of Patients with Combined Hepatocellular Carcinoma and Cholangiocarcinoma" Springer, NY, USA 16 (16): 623-629, 2009

    4 Yamashita Y, "Sclerosing hepatocellular carcinoma: radiologic finding" 18 : 347-351, 1993

    5 Yeh MM, "Pathology of combined hepatocellular-cholangiocarcinoma" 25 : 1485-1492, 2010

    6 Kassahun WT, "Management of combined hepatocellular and cholangiocarcinoma" 62 : 1271-1278, 2008

    7 이정훈, "Long-term Prognosis of Combined Hepatocellular and Cholangiocarcinoma After Curative Resection Comparison With Hepatocellular Carcinoma and Cholangiocarcinoma" LIPPINCOTT WILLIAMS & WILKINS 45 : 69-75, 201101

    8 윤순호, "Intrahepatic Mass-forming Cholangiocarcinomas: Enhancement Patterns at Multiphasic CT, with Special Emphasis on Arterial Enhancement Pattern-Correlation with Clinicopathologic Findings" RADIOLOGICAL SOC NORTH AMERICA 260 (260): 148-157, 201107

    9 Ebied O, "Hepatocellular-cholangiocarcinoma: helical computed tomography findings in 30 patients" 27 : 117-124, 2003

    10 "Hepatocellular carcinoma variants: Radiologic-pathologic correlation" American Roentgen Ray Society 193 (193): W7-W13, 2009

    11 Nishie A, "Detection of combined hepatocellular and cholangiocarcinomas on enhanced CT: comparison with histologic findings" 184 : 1157-1162, 2005

    12 Allen RA, "Combined liver cell and bile duct carcinoma" 25 : 647-655, 1949

    13 Goodman ZD, "Combined hepatocellular-cholangiocarcinoma. A histologic and immunohistochemical study" 55 : 124-135, 1985

    14 Theise ND, "Combined hepatocellular-cholangiocarcinoma, In WHO classification of tumours of the digestive system. 4th ed" IARC Press 225-227, 2010

    15 Aoki K, "Combined hepatocellular carcinoma and cholangiocarcinoma: clinical features and computed tomographic findings" 18 : 1090-1095, 1993

    16 Jarnagin WR, "Combined hepatocellular and cholangiocarcinoma: demographic, clinical, and prognostic factors" 94 : 2040-2046, 2002

    17 Fukukura Y, "Combined hepatocellular and cholangiocarcinoma: correlation between CT findings and clinicopathological features" 21 : 52-58, 1997

    18 Chantajitr S, "Combined hepatocellular and cholangiocarcinoma: clinical features and prognostic study in a Thai population" 13 : 537-542, 2006

    19 Yano Y, "Combined hepatocellular and cholangiocarcinoma: a clinicopathologic study of 26 resected cases" 33 : 283-287, 2003

    20 Choi BI, "Combined hepatocellular and cholangiocarcinoma of the liver: sonography, CT, angiography, and iodized-oil CT with pathologic correlation" 19 : 43-46, 1994

    21 Zuo HQ, "Clinicopathological characteristics of 15 patients with combined hepatocellular carcinoma and cholangiocarcinoma" 6 : 161-165, 2007

    22 Lim JH, "Cholangiocarcinoma: morphologic classification according to growth pattern and imaging findings" 181 : 819-827, 2003

    23 Lee JW, "CT features of intraductal intrahepatic cholangiocarcinoma" 175 : 721-725, 2000

    24 Taguchi J, "A clinicopathological study on combined hepatocellular and cholangiocarcinoma" 11 : 758-764, 1996

    25 Sanada Y, "A clinical study of 11 cases of combined hepatocellular-cholangiocarcinoma Assessment of enhancement patterns on dynamics computed tomography before resection" 32 : 185-195, 2005

    더보기

    분석정보

    View

    상세정보조회

    0

    Usage

    원문다운로드

    0

    대출신청

    0

    복사신청

    0

    EDDS신청

    0

    동일 주제 내 활용도 TOP

    더보기

    주제

    연도별 연구동향

    연도별 활용동향

    연관논문

    연구자 네트워크맵

    공동연구자 (7)

    유사연구자 (20) 활용도상위20명

    인용정보 인용지수 설명보기

    학술지 이력

    학술지 이력
    연월일 이력구분 이력상세 등재구분
    2024 평가 해외DB학술지평가 신청대상 (해외등재 학술지 평가)
    2021-01-01 등재 등재학술지 유지 (해외등재 학술지 평가) KCI등재
    2020-01-01 등재 등재학술지 유지 (재인증) KCI등재
    2017-01-01 등재 등재학술지 유지 (계속평가) KCI등재
    2016-11-24 학술지명변경 외국어명 : Journal of The Korean Radiological Society -> Journal of the Korean Society of Radiology (JKSR) KCI등재
    2016-11-15 학회명변경 영문명 : The Korean Radiological Society -> The Korean Society of Radiology KCI등재
    2013-01-01 등재 등재 1차 FAIL (등재유지) KCI등재
    2010-01-01 등재 등재학술지 유지 (등재유지) KCI등재
    2008-01-01 등재 등재학술지 유지 (등재유지) KCI등재
    2006-01-01 등재 등재학술지 유지 (등재유지) KCI등재
    2005-09-15 학술지명변경 한글명 : 대한방사선의학회지 -> 대한영상의학회지 KCI등재
    2003-01-01 등재 등재학술지 선정 (등재후보2차) KCI등재
    2002-01-01 등재 등재후보 1차 PASS (등재후보1차) KCI등재후보
    2000-07-01 등재 등재후보학술지 선정 (신규평가) KCI등재후보
    더보기

    학술지 인용정보

    학술지 인용정보
    기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
    2016 0.1 0.1 0.07
    KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
    0.06 0.05 0.258 0.01
    더보기

    이 자료와 함께 이용한 RISS 자료

    나만을 위한 추천자료

    해외이동버튼